Published in Med J Aust on May 29, 2001
Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border. Malar J (2010) 1.22
Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects. Antimicrob Agents Chemother (2009) 1.21
Malaria vectors of Timor-Leste. Malar J (2010) 1.03
Defining the role of mutations in Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene using an episomal Plasmodium falciparum transfection system. Antimicrob Agents Chemother (2010) 0.79
Relapsing vivax malaria. Med J Aust (2002) 0.75
Drug sensitivity of plasmodium falciparum. An in-vitro microtechnique. Lancet (1978) 5.58
Mefloquine (WR 142,490) in the treatment of human malaria. Science (1975) 5.20
A quinoline methanol (WR 30090) for treatment of acute malaria. Antimicrob Agents Chemother (1973) 2.85
Effects of chloroquine, quinine, and cycloguanil upon the maturation of asexual erythrocytic forms of two strains of Plasmodium falciparum in vitro. Am J Trop Med Hyg (1968) 2.49
Letter: Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum. Trans R Soc Trop Med Hyg (1974) 2.22
A phenanthrene methanol (WR 33063) for treatment of acute malaria. Antimicrob Agents Chemother (1973) 2.05
Enzymes of purine and pyrimidine metabolism from the human malaria parasite, Plasmodium falciparum. Mol Biochem Parasitol (1982) 1.96
Chloroquine resistance of Plasmodium falciparum in Brazil detected by a simple in vitro method. Bull World Health Organ (1971) 1.93
Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea. Am J Trop Med Hyg (1996) 1.84
Immunochromatographic test for malaria diagnosis. Lancet (1996) 1.80
Plasmodium falciparum: isolation and purification of spontaneously released merozoites by nylon membrane sieves. Exp Parasitol (1982) 1.70
Chloroquine-resistant Plasmodium vivax in Papua New Guinea. Trans R Soc Trop Med Hyg (1992) 1.51
Prophylactic activity of mefloquine hydrochloride (WR 142490) in drug-resistant malaria. Bull World Health Organ (1974) 1.45
Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria. Bull World Health Organ (1979) 1.43
Determination of the drug sensitivity of Plasmodium falciparum. JAMA (1971) 1.33
Gametocytocidal and sporontocidal effects of primaquine and of sulfadiazine with pyrimethamine in a chloroquine-resistant strain of Plasmodium falciparum. Bull World Health Organ (1968) 1.33
Phenoxypropoxybiguanides, prodrugs of DHFR-inhibiting diaminotriazine antimalarials. J Med Chem (2001) 1.29
Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administration. Antimicrob Agents Chemother (2005) 1.21
Concentration and separation of erythrocytes infected with Plasmodium falciparum by gradient centrifugation. Bull World Health Organ (1979) 1.17
Synergistic antimalarial activity of dapsone/dihydrofolate reductase inhibitors and the interaction of antifol, antipyrimidine and antipurine combinations against Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg (1987) 1.13
Increased antimalarial activity of azithromycin during prolonged exposure of Plasmodium falciparum in vitro. Int J Parasitol (1995) 1.11
In vitro inhibition of the growth of Plasmodium falciparum by Aotus serum. Bull World Health Organ (1979) 1.09
Evaluation of WR250417 (a proguanil analog) for causal prophylactic activity in the Plasmodium cynomolgi-Macaca mulatta model. Am J Trop Med Hyg (1994) 1.06
Multiple-dose kinetics in healthy volunteers and in vitro antimalarial activity of proguanil plus dapsone. Chemotherapy (1990) 1.01
Host failure in treatment of malaria with sulfalene and pyrimethamine. Ann Intern Med (1975) 1.00
Quinine disposition during malaria and during induced fever. Clin Pharmacol Ther (1976) 0.99
Chloroquine bioassay using malaria microcultures. Am J Trop Med Hyg (1993) 0.99
Asymptomatic malaria. Lancet (1970) 0.98
Gametocytocidal and sporontocidal effects of primaquine upon two strains of Plasmodium falciparum. Mil Med (1969) 0.98
Cytotoxic effects of inhibitors of de novo pyrimidine biosynthesis upon Plasmodium falciparum. Biochemistry (1994) 0.98
A field study on the effects of a combination of cycloguanil pamoate and amodiquine against malaria in the Rabaul area of New Guinea. Am J Trop Med Hyg (1966) 0.96
Marker enzymes of Plasmodium falciparum and human erythrocytes as indicators of parasite purity. J Parasitol (1982) 0.94
Effects of tetracycline against chloroquine-resistant and chloroquine-sensitive Plasmodium falciparum. Am J Trop Med Hyg (1971) 0.94
WR 238605, chloroquine, and their combinations as blood schizonticides against a chloroquine-resistant strain of Plasmodium vivax in Aotus monkeys. Am J Trop Med Hyg (1997) 0.94
Effects of minocycline against chloroquine-resistant falciparum malaria. Am J Trop Med Hyg (1972) 0.94
Erythrocytic glutathione reductase, glucose-6-phosphate dehydrogenase, and 6-phosphogluconic dehydrogenase deficiencies in populations of the United States, South Vietnam, Iran, and Ethiopia. J Lab Clin Med (1973) 0.94
Effects of quinine and of chloroquine in vitro against a strain of chloroquine-resistant Plasmodium falciparum that displays a relative resistance to quinine in vivo. Mil Med (1969) 0.93
Multiple-dose pharmacokinetics and in vitro antimalarial activity of dapsone plus pyrimethamine (Maloprim) in man. Br J Clin Pharmacol (1990) 0.93
The activity of pyrimethamine and sulphadoxine against Plasmodium falciparum determined by the in vitro microtechnique. Trans R Soc Trop Med Hyg (1983) 0.93
Falciparum malaria: the urgent need for safe and effective drugs. Annu Rev Med (1983) 0.92
A method for the determination of amodiaquine. Bull World Health Organ (1974) 0.92
Comparison of bioassay and high performance liquid chromatographic assay of artesunate and dihydroartemisinin in plasma. Acta Trop (2003) 0.92
Disposable environmental chamber for assessing the drug susceptibility of malaria parasites. Trop Med Parasitol (1993) 0.91
Effects of folic and folinic acids in the activities of cycloguanil and WR99210 against Plasmodium falciparum in erythrocytic culture. Ann Trop Med Parasitol (1997) 0.91
Doxycycline for malaria prophylaxis in Australian soldiers deployed to United Nations missions in Somalia and Cambodia. Mil Med (1995) 0.91
Visual test for erythrocytic glucose-6-phosphate dehydrogenase, 6-phosphogluconic dehydrogenase, and glutathione reductase deficiencies. J Lab Clin Med (1973) 0.90
Chemotherapeutic results in a multi-drug resistant strain of Plasmodium falciparum malaria from Vietnam. Mil Med (1974) 0.89
Risk factors of chloroquine resistance in Plasmodium falciparum malaria. Acta Trop (1996) 0.89
The activity of PS-15 in combination with sulfamethoxazole. Trop Med Parasitol (1994) 0.88
Blastoid transformation of lymphocytes in falciparum malaria. Am J Trop Med Hyg (1971) 0.87
Prolonged exposure of Plasmodium falciparum to ciprofloxacin increases anti-malarial activity. J Parasitol (1994) 0.86
Plasmodium falciparum gametocytes. Electron microscopic observations on material obtained by a new method. Am J Trop Med Hyg (1971) 0.86
Isolation of intracellular parasites (Plasmodium falciparum) from culture using free-flow electrophoresis: separation of the free parasites according to stages. J Parasitol (1982) 0.86
Pharmacokinetics of halofantrine and n-desbutylhalofantrine in patients with falciparum malaria following a multiple dose regimen of halofantrine. Eur J Clin Pharmacol (1991) 0.86
dCTP levels are maintained in Plasmodium falciparum subjected to pyrimidine deficiency or excess. Ann Trop Med Parasitol (1997) 0.85
The chemoprophylactic use of diformyl diaminodiphenyl sulfone (DFD) in falciparum malaria. Am J Trop Med Hyg (1972) 0.85
Visual in-vitro test for determining the drug sensitivity of Plasmodium falciparum. Lancet (1982) 0.85
Use of rabbit serum in the cultivation of Plasmodium falciparum. J Parasitol (1980) 0.83
Indirect inhibition by antibiotics of nucleotide and deoxynucleotide biosynthesis in Plasmodium falciparum. Southeast Asian J Trop Med Public Health (1998) 0.83
Chloroquine bioassay of plasma specimens obtained from soldiers on chloroquine plus doxycycline for malaria prophylaxis. Int J Parasitol (1996) 0.83
Oxidative activation of proguanil and dapsone acetylation in Thai soldiers. Br J Clin Pharmacol (1994) 0.83
Anti-malarial drug resistance, malnutrition and socio-economic status. Trop Med Int Health (1997) 0.83
The efficacy of WR238605 against the blood stages of a chloroquine resistant strain of Plasmodium vivax. Trans R Soc Trop Med Hyg (1995) 0.83
Acetylator phenotype and response of individuals infected with a chloroquine-resistant strain of Plasmodium falciparum to sulfalene and pyrimethamine. Am J Trop Med Hyg (1975) 0.82
A sensitive bioassay for serum cycloguanil using Plasmodium falciparum in vitro. Int J Parasitol (1988) 0.82
The influence of acetylator phenotype on the response to sulfalene in individuals with chloroquine-resistant falciparum malaria. Am J Trop Med Hyg (1978) 0.82
In vivo-in vitro model to assess chloroquine activity in monkeys. Chemotherapy (1995) 0.81
Acquired decrease in sensitivity to quinine observed during studies with a strain of chloroquine-resistant Plasmodium falciparum. Ann Trop Med Parasitol (1967) 0.81
[Clinical studies on chloroquine-resistant Plasmodium falciparum]. Clin Ter (1968) 0.81
Pigment in asexual erythrocytic forms of chloroquine-resistant Plasmodium falciparum. Ann Trop Med Parasitol (1967) 0.81
Steady-state kinetics of proguanil and its active metabolite, cycloguanil, in man. Chemotherapy (1988) 0.81
In vitro activities of the biguanide PS-15 and its metabolite, WR99210, against cycloguanil-resistant Plasmodium falciparum isolates from Thailand. Antimicrob Agents Chemother (1997) 0.80
Drug potentiation against pre-erythrocytic stages of Plasmodium falciparum. Trans R Soc Trop Med Hyg (1971) 0.80
Potentiation of the antimalarial activity of atovaquone by doxycycline against Plasmodium falciparum in vitro. Parasitol Res (1997) 0.80
Effects of diaphenylsulphone (dapsone) against Plasmodium vivax of South West Pacific origin. Trans R Soc Trop Med Hyg (1968) 0.80
Plasma chloroquine concentrations in young and older malaria patients treated with chloroquine. Acta Trop (1997) 0.79
Pharmacokinetics of chlorproguanil in man after a single oral dose of Lapudrine. Chemotherapy (1988) 0.79
Tetracycline prophylaxis for malaria. Lancet (1987) 0.78
Antimalaria activity of the triple combination of proguanil, atovaquone and dapsone. Acta Trop (1997) 0.78
Efficacy of amodiaquine against a chloroquine-resistant strain of Plasmodium vivax. Trans R Soc Trop Med Hyg (1991) 0.78
Effectiveness of doxycycline combined with primaquine for malaria prophylaxis. Med J Aust (1995) 0.77
A bioassay for mefloquine. J Parasitol (1992) 0.77
Gender differences in gastrointestinal disturbances and plasma concentrations of tafenoquine in healthy volunteers after tafenoquine administration for post-exposure vivax malaria prophylaxis. Trans R Soc Trop Med Hyg (2006) 0.77
A new repository antimalarial agent, CI-564, used in a field trial in New Guinea. Trans R Soc Trop Med Hyg (1967) 0.76
New quinoline di-Mannich base compounds with greater antimalarial activity than chloroquine, amodiaquine, or pyronaridine. Antimicrob Agents Chemother (1997) 0.76
Malaria prophylaxis/radical cure: recent experiences of the Australian Defence Force. Med Trop (Mars) (2001) 0.76
Tropical splenomegaly syndrome. Br Med J (1970) 0.75
Postexposure administration of halofantrine for the prevention of malaria. Clin Infect Dis (1993) 0.75
Immunization of rhesus monkeys with blood-stage antigens of Plasmodium knowlesi. Bull World Health Organ (1979) 0.75
NAD(P) glycohydrolase deficiency in human erythrocytes and alteration of cytosol NADH-methemoglobin diaphorase by membrane NAD-glycohydrolase activity. Proc Natl Acad Sci U S A (1973) 0.75
Harvest of Plasmodium falciparum merozoites from continuous culture. Bull World Health Organ (1979) 0.75
Effects of dual combinations of antifolates with atovaquone or dapsone on nucleotide levels in Plasmodium falciparum. Biochem Pharmacol (1997) 0.75
The activity of triple combinations of antifolate biguanides, with and without folinic acid, against plasmodium falciparum in vitro. Ann Trop Med Parasitol (1997) 0.75
Ex vivo antimalarial activity of proguanil combined with dapsone against cycloguanil-resistant Plasmodium falciparum isolates. Acta Trop (1997) 0.75
A statistical analysis of the antimalarial activity of proguanil and cycloguanil in human volunteers. Ann Trop Med Parasitol (1994) 0.75
Breeding of Aotus monkeys for human malaria research. Bull Pan Am Health Organ (1980) 0.75
Disposition of proguanil in Thai patients with uncomplicated falciparum malaria. Am J Trop Med Hyg (1997) 0.75
Field incubator for measuring drug susceptibility of Plasmodium falciparum. J Trop Med Hyg (1981) 0.75
Failure of dapsone/pyrimethamine plus chloroquine against falciparum malaria in Papua New Guinea. Lancet (1988) 0.75
Amodiaquine in malaria treatment. Trans R Soc Trop Med Hyg (1987) 0.75